55 results on '"Wilschanski, Michael"'
Search Results
2. Training in Paediatric Clinical Nutrition Across Europe: A Survey of the National Societies Network (2016–2019) of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition
3. Health-Related Quality of Life in Pediatric Acute Recurrent or Chronic Pancreatitis: Association With Biopsychosocial Risk Factors
4. International Survey on Severe Acute Respiratory Syndrome Coronavirus 2 and Acute Pancreatitis Co-occurrence in Children
5. Management of Gastrointestinal and Nutritional Problems in Children with Neurological Impairment: A Survey of Practice
6. Clinical and Practice Variations in Pediatric Acute Recurrent or Chronic Pancreatitis: Report From The Insppire Study
7. Drugs in Focus: Proton Pump Inhibitors
8. Factors Associated With Frequent Opioid Use in Children With Acute Recurrent and Chronic Pancreatitis
9. Factors Associated With Frequent Opioid Use in Children With Acute Recurrent and Chronic Pancreatitis
10. Diabetes Mellitus in Children with Acute Recurrent and Chronic Pancreatitis: Data from the INSPPIRE Cohort
11. Increasing Vitamin D Serum Levels Is Associated with Reduced Pulmonary Exacerbations in Patients with Cystic Fibrosis
12. Prevention of malnutrition in cystic fibrosis
13. Diabetes Mellitus in Children with Acute Recurrent and Chronic Pancreatitis: Data From the INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE Cohort
14. The Use of Jejunal Tube Feeding in Children: A Position Paper by the Gastroenterology and Nutrition Committees of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition 2019
15. Risk Factors for Rapid Progression From Acute Recurrent to Chronic Pancreatitis in Children: Report From INSPPIRE
16. Pancreas Divisum in Pediatric Acute Recurrent and Chronic Pancreatitis: Report From INSPPIRE
17. Chronic Pancreatitis: Pediatric and Adult Cohorts Show Similarities in Disease Progress Despite Different Risk Factors
18. Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis
19. INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE Cohort Study: Design and Rationale for INSPPIRE 2 From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
20. Impact of Obesity on Pediatric Acute Recurrent and Chronic Pancreatitis
21. Recommendations for Diagnosis and Management of Autoimmune Pancreatitis in Childhood: Consensus From INSPPIRE
22. Nutritional Considerations in Pediatric Pancreatitis: A Position Paper from the NASPGHAN Pancreas Committee and ESPGHAN Cystic Fibrosis/Pancreas Working Group
23. CFTR Protein Function Modulation Therapy Is Finally Targeting Cystic Fibrosis-related Gastrointestinal Disease
24. Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis
25. Role of Polyethylene Glycol in the Treatment of Functional Constipation in Children
26. Cystic Fibrosis–related Liver Disease: Research Challenges and Future Perspectives
27. Causal Evaluation of Acute Recurrent and Chronic Pancreatitis in Children: Consensus From the INSPPIRE Group
28. Functional gastro-intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies
29. Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease
30. Diagnosis of Cystic Fibrosis in Screened Populations
31. Pediatric Chronic Pancreatitis Is Associated with Genetic Risk Factors and Substantial Disease Burden
32. Differences in the Pattern of Structural Abnormalities on CT Scan in Patients With Cystic Fibrosis and Pancreatic Sufficiency or Insufficiency
33. Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis
34. TARGETING CLASS 1 MUTATIONS: UPDATE ON ATALUREN AS A PROMISING TREATMENT FOR NONSENSE MUTATION CF: S1.1
35. 50 Years Ago in The Journal of Pediatrics
36. Small Molecules to Treat Cystic Fibrosis
37. An International Randomized Multicenter Comparison of Nasal Potential Difference Techniques
38. Genetic Modifiers of Liver Disease in Cystic Fibrosis
39. DIOS AND CONSTIPATION IN CF: S5.3
40. Nasal Potential Difference in Non-Classic Cystic Fibrosis—Long Term Follow Up
41. Reproducibility of Nasal Potential Difference Measurements in Cystic Fibrosis*
42. Patterns of GI disease in adulthood associated with mutations in the CFTR gene
43. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
44. Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials
45. ORAL PROBIOTICS PREVENT NECROTIZING ENTEROCOLITIS IN VERY LOW BIRTH WEIGHT NEONATES
46. Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations
47. Decreased Postnatal Docosahexaenoic and Arachidonic Acid Blood Levels in Premature Infants are Associated with Neonatal Morbidities
48. A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations
49. Rectal biopsy in the investigation of constipation
50. Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.